Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA415665
Max Phase: Preclinical
Molecular Formula: C35H60N2O6
Molecular Weight: 604.87
Molecule Type: Small molecule
Associated Items:
ID: ALA415665
Max Phase: Preclinical
Molecular Formula: C35H60N2O6
Molecular Weight: 604.87
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1CCC2(CC1)OOC1(CC[C@@]3(C)[C@H](CC[C@@H]4[C@@H]3C[C@H](O)[C@]3(C)[C@@H]([C@H](C)CCC(=O)NCCN(C)C)CC[C@@H]43)C1)OO2
Standard InChI: InChI=1S/C35H60N2O6/c1-23-13-15-34(16-14-23)40-42-35(43-41-34)18-17-32(3)25(22-35)8-9-26-28-11-10-27(33(28,4)30(38)21-29(26)32)24(2)7-12-31(39)36-19-20-37(5)6/h23-30,38H,7-22H2,1-6H3,(H,36,39)/t23?,24-,25-,26+,27-,28+,29+,30+,32+,33-,34?,35?/m1/s1
Standard InChI Key: UULKGBQIQAIXSZ-MIQKEFCNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 604.87 | Molecular Weight (Monoisotopic): 604.4451 | AlogP: 6.22 | #Rotatable Bonds: 7 |
Polar Surface Area: 89.49 | Molecular Species: BASE | HBA: 7 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 8.51 | CX LogP: 6.19 | CX LogD: 5.05 |
Aromatic Rings: 0 | Heavy Atoms: 43 | QED Weighted: 0.33 | Np Likeness Score: 1.41 |
1. Terzić N, Opsenica D, Milić D, Tinant B, Smith KS, Milhous WK, Solaja BA.. (2007) Deoxycholic acid-derived tetraoxane antimalarials and antiproliferatives(1)., 50 (21): [PMID:17887664] [10.1021/jm070684m] |
2. Terzić N, Opsenica D, Milić D, Tinant B, Smith KS, Milhous WK, Solaja BA.. (2007) Deoxycholic acid-derived tetraoxane antimalarials and antiproliferatives(1)., 50 (21): [PMID:17887664] [10.1021/jm070684m] |
Source(1):